WHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer

WHO suggests using the following strategy for cervical cancer prevention among women living with HIV: HPV DNA detection in a screen, triage and treat approach starting at the age

WHO suggests that women from the general population and women living with HIV who have screened positive on a cytology primary screening test and then have normal results

We assumed 0.000339 of the population treated with cryotherapy, 0.002257 with LEEP, and 0.001705 with CKC, based on pooled proportions in observational studies with no

between the two cumulative exposure scores and late smear test: risk for late cervical cancer screening was found to be higher women living and remaining daily in poor

This study suggests that male primary care physician sex remains associated with lower rates of cervical cancer screening despite changes in medical practice, culture,

In 1999, five international health organizations came to- gether to create the Alliance for Cervical Cancer Prevention (ACCP).* For the next eight years, with support from the

General practitioner management related to skin cancer prevention and screening during standard medical encounters: a French cross- sectional study based on the

CC: Cervical cancer; CCS: Cervical cancer screening; SHIS: Swiss Health Interview Survey; BHIS: Belgian Health Interview Survey; CH: Switzerland; BE: Belgium; APR: Adjusted